{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:12:46Z","timestamp":1790061166304,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00702-011-0653-2","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T13:20:40Z","timestamp":1304688040000},"page":"795-808","source":"Crossref","is-referenced-by-count":256,"title":["Parkinson\u2019s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures"],"prefix":"10.1007","volume":"118","author":[{"given":"Mansoureh","family":"Hakimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumahal","family":"Selvanantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Swinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth F.","family":"Padmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youren","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Kabbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Venderova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Girardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Bulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens R.","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"LaVoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Gris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana J.","family":"Philpott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Schlossmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,7]]},"reference":[{"key":"653_CR1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coi.2004.11.006","volume":"17","author":"A Alca\u00efs","year":"2005","unstructured":"Alca\u00efs A, Mira M, Casanova JL, Schurr E, Abel L (2005) Genetic dissection of immunity in leprosy. Curr Opin Immunol 17:44\u201348","journal-title":"Curr Opin Immunol"},{"key":"653_CR2","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1093\/hmg\/ddp346","volume":"18","author":"J Alegre-Abarrategui","year":"2009","unstructured":"Alegre-Abarrategui J, Christian H, Lufino MM, Mutihac R, Venda LL, Ansorge O, Wade-Martins R (2009) LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 18:4022\u20134034","journal-title":"Hum Mol Genet"},{"key":"653_CR3","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.0914876107","volume":"107","author":"H Aleyasin","year":"2010","unstructured":"Aleyasin H, Rousseaux MW, Marcogliese PC, Hewitt SJ, Irrcher I, Joselin AP, Parsanejad M, Kim RH, Rizzu P, Callaghan SM, Slack RS, Mak TW, Park DS (2010) DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci USA 107:3186\u20133191","journal-title":"Proc Natl Acad Sci USA"},{"key":"653_CR4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","volume":"40","author":"JC Barrett","year":"2008","unstructured":"Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, NIDDK IBD Genetics Consortium, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E, Belgian-French IBD Consortium, Wellcome Trust Case Control Consortium, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwilliam R, Tremelling M, Deloukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease. Nat Genet 40:955\u2013962","journal-title":"Nat Genet"},{"key":"653_CR5","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/bi100157u","volume":"49","author":"Z Berger","year":"2010","unstructured":"Berger Z, Smith KA, Lavoie MJ (2010) Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry 49:5511\u20135523","journal-title":"Biochemistry"},{"key":"653_CR6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2202-8-102","volume":"8","author":"S Biskup","year":"2007","unstructured":"Biskup S, Moore DJ, Rea A, Lorenz-Deperieux B, Coombes CE, Dawson VL, Dawson TM, West AB (2007) Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC Neurosci 8:102","journal-title":"BMC Neurosci"},{"key":"653_CR100","doi-asserted-by":"crossref","unstructured":"Braak H, R\u00fcb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517\u2013536","DOI":"10.1007\/s00702-002-0808-2"},{"key":"653_CR7","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC, Hunot S (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119:182\u2013192","journal-title":"J Clin Invest"},{"key":"653_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1489\/1544-581X(2004)072<0169:LOLSTP>2.0.CO;2","volume":"72","author":"E Buschman","year":"2004","unstructured":"Buschman E, Skamene E (2004) Linkage of leprosy susceptibility to Parkinson\u2019s disease genes. Int J Lepr Other Mycobact Dis 72:169\u2013170","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"653_CR9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","volume":"167","author":"H Chen","year":"2008","unstructured":"Chen H, O\u2019Reilly EJ, Schwarzschild MA, Ascherio A (2008) Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease. Am J Epidemiol 167:90\u201395","journal-title":"Am J Epidemiol"},{"key":"653_CR10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","volume":"11","author":"MR Cookson","year":"2010","unstructured":"Cookson MR (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease. Nat Rev Neurosci 11:791\u2013797","journal-title":"Nat Rev Neurosci"},{"key":"653_CR11","doi-asserted-by":"crossref","unstructured":"Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, Boston H, Saftig P, Woulfe J, Feany MB, Myllykangas L, Schlossmacher MG, Tyynel\u00e4 J (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain. doi: 10.1186\/1756-6606-2-5","DOI":"10.1186\/1756-6606-2-5"},{"key":"653_CR12","doi-asserted-by":"crossref","unstructured":"Cullen V, Sardi SP, Ng J, Xu YH, Sun Y, Tomlinson JJ, Kolodziej P, Kahn I, Saftig P, Woulfe J, Rochet JC, Glicksman MA, Cheng SH, Grabowski GA, Shihabuddin LS, Schlossmacher MG (2011) Acid \u03b2-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter \u03b1-synuclein processing. Ann Neurol. doi: 10.1002\/ana.22400","DOI":"10.1002\/ana.22400"},{"key":"653_CR13","doi-asserted-by":"crossref","first-page":"e1001195","DOI":"10.1371\/journal.pgen.1001195","volume":"6","author":"P Danoy","year":"2010","unstructured":"Danoy P, Pryce K, Hadler J, Bradbury LA, Farrar C, Pointon J, Australo-Anglo-American Spondyloarthritis Consortium, Ward M, Weisman M, Reveille JD, Wordsworth BP, Stone MA, Spondyloarthritis Research Consortium of Canada, Maksymowych WP, Rahman P, Gladman D, Inman RD, Brown MA (2010) Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn\u2019s disease. PLoS Genet 6:e1001195","journal-title":"PLoS Genet"},{"key":"653_CR14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.20808","volume":"59","author":"D Galter","year":"2006","unstructured":"Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, Olson L (2006) LRRK2 expression linked to dopamine-innervated areas. Ann Neurol 59:714\u2013719","journal-title":"Ann Neurol"},{"key":"653_CR15","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","volume":"185","author":"A Gardet","year":"2010","unstructured":"Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik JR, Rioux JD, Daly MJ, Xavier RJ, Podolsky DK (2010) LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol 185:5577\u20135585","journal-title":"J Immunol"},{"key":"653_CR101","doi-asserted-by":"crossref","unstructured":"Goldwurm S, Zini M, Mariani L, Tesei S, Miceli R, Sironi F, Clementi M, Bonifati V, Pezzoli G (2007) Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology 68:1141\u20131143","DOI":"10.1212\/01.wnl.0000254483.19854.ef"},{"key":"653_CR16","doi-asserted-by":"crossref","unstructured":"Greggio E, Cookson MR (2009) Leucine-rich repeat kinase 2 mutations and Parkinson\u2019s disease: three questions. ASN Neuro 1:13\u201324","DOI":"10.1042\/AN20090007"},{"key":"653_CR17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1017\/S0317167100006788","volume":"34","author":"DA Grimes","year":"2007","unstructured":"Grimes DA, Racacho L, Han F, Panisset M, Bulman DE (2007) LRRK2 screening in a Canadian Parkinson\u2019s disease cohort. Can J Neurol Sci 34:336\u2013338","journal-title":"Can J Neurol Sci"},{"key":"653_CR18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397","journal-title":"Lancet Neurol"},{"key":"653_CR19","doi-asserted-by":"crossref","unstructured":"Jellinger KA (2011) Changing concepts in Parkinson\u2019s disease. Lancet Neurol 10:307","DOI":"10.1016\/S1474-4422(11)70064-3"},{"key":"653_CR20","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/01.wnl.0000271880.27321.a7","volume":"69","author":"C Klein","year":"2007","unstructured":"Klein C, Schlossmacher MG (2007) Parkinson disease, 10\u00a0years after its genetic revolution: multiple clues to a complex disorder. Neurology 69:2093\u20132104","journal-title":"Neurology"},{"key":"653_CR21","doi-asserted-by":"crossref","unstructured":"Klein C, Krainc D, Schlossmacher MG, Lang AE (2011) Translational Research in Neurology and Neuroscience 2011: movement Disorders. Arch Neurol. doi: 10.1001\/archneurol.2011.11","DOI":"10.1001\/archneurol.2011.11"},{"key":"653_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.07.021","volume":"229","author":"M Kubo","year":"2010","unstructured":"Kubo M, Kamiya Y, Nagashima R, Maekawa T, Eshima K, Azuma S, Ohta E, Obata F (2010) LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation. J Neuroimmunol 229:123\u2013128","journal-title":"J Neuroimmunol"},{"key":"653_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2010.06.007","volume":"8","author":"M Lamkanfi","year":"2010","unstructured":"Lamkanfi M, Dixit VM (2010) Manipulation of host cell death pathways during microbial infections. Cell Host Microb 8:44\u201354","journal-title":"Cell Host Microb"},{"key":"653_CR24","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1128\/IAI.00519-09","volume":"77","author":"L Le Bourhis","year":"2009","unstructured":"Le Bourhis L, Magalhaes JG, Selvanantham T, Travassos LH, Geddes K, Fritz JH, Viala J, Tedin K, Girardin SE, Philpott DJ (2009) Role of Nod1 in mucosal dendritic cells during Salmonella pathogenicity island 1-independent Salmonella enterica serovar Typhimurium infection. Infect Immun 77:4480\u20134486","journal-title":"Infect Immun"},{"key":"653_CR25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1103685","volume":"307","author":"S Maeda","year":"2005","unstructured":"Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, Eckmann L, Karin M (2005) NOD2 mutation in Crohn\u2019s disease potentiates NF-\u03baB activity and IL-1\u03b2 processing. Science 307:734\u2013738","journal-title":"Science"},{"key":"653_CR26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2010.01.041","volume":"392","author":"T Maekawa","year":"2010","unstructured":"Maekawa T, Kubo M, Yokoyama I, Ohta E, Obata F (2010) Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen. Biochem Biophys Res Commun 392:431\u2013435","journal-title":"Biochem Biophys Res Commun"},{"key":"653_CR27","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1093\/molbev\/msl114","volume":"23","author":"I Mar\u00edn","year":"2006","unstructured":"Mar\u00edn I (2006) The Parkinson disease gene LRRK2: evolutionary and structural insights. Mol Biol Evol 23:2423\u20132433","journal-title":"Mol Biol Evol"},{"key":"653_CR28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tins.2006.03.006","volume":"29","author":"IF Mata","year":"2006","unstructured":"Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA (2006) LRRK2 in Parkinson\u2019s disease: protein domains and functional insights. Trends Neurosci 29:286\u2013293","journal-title":"Trends Neurosci"},{"key":"653_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/14796708.3.6.669","volume":"3","author":"H Melrose","year":"2008","unstructured":"Melrose H (2008) Update on the functional biology of Lrrk2. Future Neurol 3:669\u2013681","journal-title":"Future Neurol"},{"key":"653_CR30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","volume":"65","author":"J Miklossy","year":"2006","unstructured":"Miklossy J, Arai T, Guo JP, Klegeris A, Yu S, McGeer EG, McGeer PL (2006) LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol 65:953\u2013963","journal-title":"J Neuropathol Exp Neurol"},{"key":"653_CR31","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS (2007) Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 27:3328\u20133337","journal-title":"J Neurosci"},{"key":"653_CR102","doi-asserted-by":"crossref","unstructured":"Mutez E, Larvor L, Lepr\u00eatre F, Mouroux V, Hamalek D, Kerckaert JP, P\u00e9rez-Tur J, Waucquier N, Vanbesien-Mailliot C, Duflot A, Devos D, Defebvre L, Kreisler A, Frigard B, Dest\u00e9e A, Chartier-Harlin MC (2010) Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2009.10.016","DOI":"10.1016\/j.neurobiolaging.2009.10.016"},{"key":"653_CR32","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","volume":"132","author":"J Neumann","year":"2009","unstructured":"Neumann J, Bras J, Deas E, O\u2019Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, Segarane B, Singleton A, Lees A, Hardy J, Houlden H, Revesz T, Wood NW (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain 132:1783\u20131794","journal-title":"Brain"},{"key":"653_CR33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nu\u00f1ez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 411:603\u2013606","journal-title":"Nature"},{"key":"653_CR103","doi-asserted-by":"crossref","unstructured":"Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354:424\u2013425","DOI":"10.1056\/NEJMc055509"},{"key":"653_CR34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2174\/138955709789055199","volume":"9","author":"M Reale","year":"2009","unstructured":"Reale M, Greig NH, Kamal MA (2009) Peripheral chemo-cytokine profiles in Alzheimer\u2019s and Parkinson\u2019s diseases. Mini Rev Med Chem 9:1229\u20131241","journal-title":"Mini Rev Med Chem"},{"key":"653_CR35","doi-asserted-by":"crossref","first-page":"e10008","DOI":"10.1371\/journal.pone.0010008","volume":"5","author":"N Sa\u00efd-Sadier","year":"2010","unstructured":"Sa\u00efd-Sadier N, Padilla E, Langsley G, Ojcius DM (2010) Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS One 5:e10008","journal-title":"PLoS One"},{"key":"653_CR36","doi-asserted-by":"crossref","unstructured":"Scherzer CR, Grass JA, Liao Z, Pepivani I, Zheng B, Eklund AC, Ney PA, Ng J, McGoldrick M, Mollenhauer B, Bresnick EH, Schlossmacher MG (2008) GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proc Natl Acad Sci USA. 105:10907\u201310912","DOI":"10.1073\/pnas.0802437105"},{"key":"653_CR37","first-page":"351","volume":"301","author":"MG Schlossmacher","year":"2005","unstructured":"Schlossmacher MG, Shimura H (2005) Parkinson\u2019s disease: assays for the ubiquitin ligase activity of neural Parkin. Methods Mol Biol 301:351\u2013369","journal-title":"Methods Mol Biol"},{"key":"653_CR38","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)61113-3","volume":"160","author":"MG Schlossmacher","year":"2002","unstructured":"Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, Langston JW, Mizuno Y, Hyman BT, Selkoe DJ, Kosik KS (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 160:1655\u20131667","journal-title":"Am J Pathol"},{"key":"653_CR39","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMe0910690","volume":"361","author":"E Schurr","year":"2009","unstructured":"Schurr E, Gros P (2009) A common genetic fingerprint in leprosy and Crohn\u2019s disease. N Engl J Med 361:2666\u20132668","journal-title":"N Engl J Med"},{"key":"653_CR40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.smim.2006.07.005","volume":"18","author":"E Schurr","year":"2006","unstructured":"Schurr E, Alca\u00efs A, de L\u00e9s\u00e9leuc L, Abel L (2006) Genetic predisposition to leprosy: a major gene reveals novel pathways of immunity to Mycobacterium leprae. Semin Immunol 18:404\u2013410","journal-title":"Semin Immunol"},{"key":"653_CR41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kr\u00fcger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312","journal-title":"Nat Genet"},{"key":"653_CR42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.femsim.2004.02.004","volume":"41","author":"JC Stockton","year":"2004","unstructured":"Stockton JC, Howson JM, Awomoyi AA, McAdam KP, Blackwell JM, Newport MJ (2004) Polymorphism in NOD2, Crohn\u2019s disease, and susceptibility to pulmonary tuberculosis. FEMS Immunol Med Microbiol 41:157\u2013160","journal-title":"FEMS Immunol Med Microbiol"},{"key":"653_CR43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1126\/science.1171666","volume":"324","author":"FL Takken","year":"2009","unstructured":"Takken FL, Tameling WI (2009) To nibble at plant resistance proteins. Science 324:744\u2013746","journal-title":"Science"},{"key":"653_CR44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.chom.2010.06.005","volume":"8","author":"DJ Taxman","year":"2010","unstructured":"Taxman DJ, Huang MT, Ting JP (2010) Inflammasome inhibition as a pathogenic stealth mechanism. Cell Host Microbe 8:7\u201311","journal-title":"Cell Host Microbe"},{"key":"653_CR45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2005.12.004","volume":"12","author":"JP Taylor","year":"2006","unstructured":"Taylor JP, Mata IF, Farrer MJ (2006) LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? Trends Mol Med 12:76\u201382","journal-title":"Trends Mol Med"},{"key":"653_CR46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neuron.2009.12.017","volume":"64","author":"Y Tong","year":"2009","unstructured":"Tong Y, Shen J (2009) Alpha-synuclein and LRRK2: partners in crime. Neuron 64:771\u2013773","journal-title":"Neuron"},{"key":"653_CR47","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0906334106","volume":"106","author":"Y Tong","year":"2009","unstructured":"Tong Y, Pisani A, Martella G, Karouani M, Yamaguchi H, Pothos EN, Shen J (2009) R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc Natl Acad Sci USA 106:14622\u201314627","journal-title":"Proc Natl Acad Sci USA"},{"key":"653_CR48","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.1004676107","volume":"107","author":"Y Tong","year":"2010","unstructured":"Tong Y, Yamaguchi H, Giaime E, Boyle S, Kopan R, Kelleher RJ 3rd, Shen J (2010) Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci USA 107:9879\u20139884","journal-title":"Proc Natl Acad Sci USA"},{"key":"653_CR49","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.embor.7400248","volume":"5","author":"LH Travassos","year":"2004","unstructured":"Travassos LH, Girardin SE, Philpott DJ, Blanot D, Nahori MA, Werts C, Boneca IG (2004) Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 5:1000\u20131006","journal-title":"EMBO Rep"},{"key":"653_CR50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ni.1823","volume":"11","author":"LH Travassos","year":"2010","unstructured":"Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalh\u00e3es JG, Yuan L, Soares F, Chea E, Le Bourhis L, Boneca IG, Allaoui A, Jones NL, Nu\u00f1ez G, Girardin SE, Philpott DJ (2010) Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 11:55\u201362","journal-title":"Nat Immunol"},{"key":"653_CR51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-genom-082908-150013","volume":"10","author":"J Limbergen Van","year":"2009","unstructured":"Van Limbergen J, Wilson DC, Satsangi J (2009) The genetics of Crohn\u2019s disease. Annu Rev Genomics Hum Genet 10:89\u2013116","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"653_CR52","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1093\/hmg\/ddp394","volume":"18","author":"K Venderova","year":"2009","unstructured":"Venderova K, Kabbach G, Abdel-Messih E, Zhang Y, Parks RJ, Imai Y, Gehrke S, Ngsee J, Lavoie MJ, Slack RS, Rao Y, Zhang Z, Lu B, Haque ME, Park DS (2009) Leucine-rich repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson\u2019s disease. Hum Mol Genet 18:4390\u20134404","journal-title":"Hum Mol Genet"},{"key":"653_CR53","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1189\/jlb.0710430","volume":"89","author":"A Vranjkovic","year":"2011","unstructured":"Vranjkovic A, Crawley AM, Patey A, Angel JB (2011) IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection. J Leukoc Biol 89:499\u2013506","journal-title":"J Leukoc Biol"},{"key":"653_CR54","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/eji.200737069","volume":"37","author":"C Werts","year":"2007","unstructured":"Werts C, le Bourhis L, Liu J, Magalhaes JG, Carneiro LA, Fritz JH, Stockinger S, Balloy V, Chignard M, Decker T, Philpott DJ, Ma X, Girardin SE (2007) Nod1 and Nod2 induce CCL5\/RANTES through the NF-\u03baB pathway. Eur J Immuno 37:2499\u20132508","journal-title":"Eur J Immuno"},{"key":"653_CR55","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM (2005) Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 102:16842\u201316847","journal-title":"Proc Natl Acad Sci USA"},{"key":"653_CR56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000289232","volume":"7","author":"C Wider","year":"2010","unstructured":"Wider C, Dickson DW, Wszolek ZK (2010) Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener Dis 7:175\u2013179","journal-title":"Neurodegener Dis"},{"key":"653_CR57","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","volume":"361","author":"FR Zhang","year":"2009","unstructured":"Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, Cui Y, Yan XX, Yang HT, Yang RD, Chu TS, Zhang C, Zhang L, Han JW, Yu GQ, Quan C, Yu YX, Zhang Z, Shi BQ, Zhang LH, Cheng H, Wang CY, Lin Y, Zheng HF, Fu XA, Zuo XB, Wang Q, Long H, Sun YP, Cheng YL, Tian HQ, Zhou FS, Liu HX, Lu WS, He SM, Du WL, Shen M, Jin QY, Wang Y, Low HQ, Erwin T, Yang NH, Li JY, Zhao X, Jiao YL, Mao LG, Yin G, Jiang ZX, Wang XD, Yu JP, Hu ZH, Gong CH, Liu YQ, Liu RY, Wang DM, Wei D, Liu JX, Cao WK, Cao HZ, Li YP, Yan WG, Wei SY, Wang KJ, Hibberd ML, Yang S, Zhang XJ, Liu JJ (2009) Genomewide association study of leprosy. N Engl J Med 361:2609\u20132618","journal-title":"N Engl J Med"},{"key":"653_CR58","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, M\u00fcller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607","journal-title":"Neuron"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-011-0653-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0653-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T15:43:43Z","timestamp":1560181423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0653-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["653"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0653-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}